Polymorphic repeat in AIB1 does not alter breast cancer risk

Statement of findingsWe assessed the association between a glutamine repeat polymorphism in AIB1 and breast cancer risk in a case-control study (464 cases, 624 controls) nested within the Nurses' Health Study cohort. We observed no association between AIB1 genotype and breast cancer incidence, or specific tumor characteristics. These findings suggest that AIB1 repeat genotype does not influence postmenopausal breast cancer risk among Caucasian women in the general population.

• Publication year

  2000

• Venue

  Breast Cancer Research

• Publication date

  2000-06-19

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1186/bcr82PMID 11056690PMCID 13920
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Amplified in breast cancer-1 glutamine repeat and prostate cancer risk

  2000cited by this paper
• Constitutional genetic variation at the human aromatase gene (Cyp19) and breast cancer risk

  1999cited by this paper
• Androgen receptor exon 1 CAG repeat length and breast cancer in women before age forty years.

  1999cited by this paper
• The relationship between a polymorphism in CYP17 with plasma hormone levels and breast cancer.

  1999influential reference
• Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women.

  1998cited by this paper
• Progesterone receptor gene polymorphism and risk for breast and ovarian cancer.

  1998cited by this paper
• ENDOGENOUS HORMONES AND BREAST CANCER

  1998cited by this paper
• In breast cancer, amplification of the steroid receptor coactivator gene AIB1 is correlated with estrogen and progesterone receptor positivity.

  1998cited by this paper
• Relationship between estrogen levels, use of hormone replacement therapy, and breast cancer.

  1998cited by this paper
• Estrogen receptor polymorphism at codon 325 and risk of breast cancer in women before age forty.

  1998cited by this paper
• Coactivation and corepression in transcriptional regulation by steroid/nuclear hormone receptors.

  1998influential reference
• A rare CYP19 (aromatase) variant may increase the risk of breast cancer.

  1998cited by this paper
• Polymorphic exonic CAG microsatellites in the gene amplified in breast cancer (AIB1 gene)

  1998cited by this paper
• The CAG repeat within the androgen receptor gene and its relationship to prostate cancer.

  1997cited by this paper
• A polymorphism in the CYP17 gene increases the risk of breast cancer.

  1997cited by this paper
• AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer.

  1997influential reference
• Reproducibility of plasma hormone levels in postmenopausal women over a 2-3-year period.

  1995cited by this paper
• The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function.

  1994cited by this paper
• Human familial and sporadic breast cancer: analysis of the coding regions of the 17β-hydroxysteroid dehydrogenase 2 gene (EDH17B2) using a single-strand conformation polymorphism assay

  1994cited by this paper
• Oestrogen receptor (ESR) polymorphisms and breast cancer susceptibility

  1994cited by this paper
• Endogenous hormones and breast cancer risk.

  1993cited by this paper
• Regression analysis for correlated data.

  1993cited by this paper

• Polymorphic Repeat Length in the AIB1 Gene and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: A Meta-Analysis of Observational Studies

  2013cites this paper
• AIB1 polymorphisms with breast cancer susceptibility: a pooled analysis of variation in BRCA1/2 mutation carriers and non–carriers

  2012influential citation
• AIB1: A Transcriptional Coactivator Which Integrates Signaling Cross Talk in Cancer Cells

  2012cites this paper
• NCOA3 (Nuclear Receptor Coactivator 3)

  2011cites this paper
• The AIB1 gene polyglutamine repeat length polymorphism and the risk of breast cancer development

  2010cites this paper
• The role of SRC-3 in human breast cancer

  2010cites this paper
• Screening and association testing of common coding variation in steroid hormone receptor co-activator and co-repressor genes in relation to breast cancer risk: the Multiethnic Cohort

  2009cites this paper
• BRCA1-associated breast and ovarian cancer risks in Poland: no association with commonly studied polymorphisms

  2009cites this paper
• Use of association studies to define genetic modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriers

  2008cites this paper
• Genetic Predisposition to Breast and Ovarian Cancer in Eastern Finnish

  2007cites this paper
• Cancer genetics of epigenetic genes.

  2007cites this paper
• Polymorphisms of short tandem repeat of genes and breast cancer susceptibility.

  2007cites this paper
• The AIB1 glutamine repeat polymorphism is not associated with risk of breast cancer before age 40 years in Australian women

  2005influential citation
• Polyglutamine repeat length in the NCOA3 does not affect risk in familial breast cancer.

  2005influential citation
• Association of NCOA3 Polymorphisms with Breast Cancer Risk

  2005cites this paper
• Null Results in Brief Polyglutamine Repeat Length in the NCOA 3 Does Not Affect Risk in Familial Breast Cancer

  2005cites this paper
• Breast cancer risk in BRCA1 and BRCA2 mutation carriers and polyglutamine repeat length in the AIB1 gene

  2005cites this paper
• Polymorphisms in Steroid Hormone Pathway Genes and Mammographic Density

  2004cites this paper
• Polyglutamine repeat length in the AIB1 gene modifies breast cancer susceptibility in BRCA1 carriers

  2004cites this paper
• Somatic instability of the DNA sequences encoding the polymorphic polyglutamine tract of the AIB1 gene

  2003cites this paper
• [Pharmacogenomics in gynecology. Replies to the Zurich Discussion Panel].

  2003cites this paper
• Pharmakogenomik in der Frauenheilkunde

  2002cites this paper
• [Genetic alterations of transcription cofactors in solid tumors].

  2002cites this paper
• Gene expression in inherited breast cancer.

  2002cites this paper
• Modification of BRCA1- and BRCA2-associated breast cancer risk by AIB1 genotype and reproductive history.

  2001cites this paper
• Genetic susceptibility for breast cancer--risk assessment and counseling.

  2001cites this paper
• Modification of BRCA 1-and BRCA 2-associated Breast Cancer Risk by AIB 1 Genotype and Reproductive History 1

  2001cites this paper
• Genetic factors related to racial variation in plasma levels of insulin-like growth factor-1: implications for premenopausal breast cancer risk.

  2001cites this paper